Felicitex Therapeutics Inc. Email Format

Pharmaceutical ManufacturingMassachusetts, United States2-10 Employees

Felicitex Therapeutics Inc. is a pharmaceutical manufacturing company focused on discovering therapies and diagnostic assays aimed at dormant or quiescent cancer cells. Its work targets cancers that are often resistant to standard treatments, including pancreatic, colorectal, non-small cell lung, and ovarian cancers, with the goal of improving long-term treatment outcomes for patients. The organization positions itself within oncology research, pursuing solutions that address the challenge of cancer cell dormancy to enhance effectiveness in existing therapeutic approaches. Based in Natick, Massachusetts, the company operates with a small team and concentrates its efforts on drug discovery activities relevant to difficult-to-treat malignancies. A notable recent development is that Felicitex Therapeutics went public in late 2022, reflecting a broader milestone in its corporate trajectory within the biopharmaceutical landscape.

Sign up for free to view info

Company overview Employee directory